Trial Profile
Multicentre clinical trial to evaluate the analgesic efficacy and safety of Dexketoprofen (50 mg iv single dose, followed by oral dose of 25 mg t.i.d.) vs. Metamizol [dipyrone] (2 g iv single dose, and 575 mg t.i.d oral) for the treatment of pain subsequent to ambulatory surgery
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Apr 2022
Price :
$35
*
At a glance
- Drugs Dexketoprofen (Primary) ; Dexketoprofen (Primary) ; Dipyrone; Dipyrone
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Menarini
- 07 Apr 2022 Status changed from active, no longer recruiting to completed.
- 13 Mar 2008 New trial record.